Acoramidis (AG10)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Acoramidis (AG10), covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN) [Phase 3]